MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurostimulation"

  • 2017 International Congress

    Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of DBS for Parkinson’s disease

    G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, M. Pötter-Nerger, L. Timmermann, J. Volkmann, A. Kühn, P. Eldridge, J. Fitzgerald, H. Mehdorn, J. Vesper (Kiel, Germany)

    Objective: To evaluate clinical outcomes in subjects implanted with a Directional Lead for use in the treatment of levodopa-responsive Parkinson’s disease (PD) as part of…
  • 2016 International Congress

    DTI tractographic correlates of weight gain in Parkinson’s disease patients after STN DBS

    O.F. Ahmad, L. Huang, N. Vanegas-Arroyave, K. Zaghloul, S.G. Horovitz, C. Lungu (Bethesda, MD, USA)

    Objective: To assess DTI connectivity patterns and correlations with weight gain in Parkinson's disease patients after STN DBS. Background: Weight gain is a well-known adverse…
  • 2016 International Congress

    Unilateral dual lead thalamic deep brain stimulation improves refractory essential tremor

    D. Isaacs, J.T. Butler, C. Tolleson, F. Phibbs, J. Fang, P. Hedera (Nashville, TN, USA)

    Objective: To report on the results of utilization of multiple ipsilateral leads for DBS treatment of essential tremor. Background: Thalamic VIM DBS (deep brain stimulation)…
  • 2016 International Congress

    Bacterial biofilm formation on neurostimulation systems

    A. Wloch, B. Hong, M. Abdallat, A. Winkel, A. Saryyeva, G. Lütjens, M. Stiesch, J.K. Krauss (Hannover, Germany)

    Objective: The aim of this study is to identify specifically the DNA of bacterial biofilm on neurostimulation systems using polymerase chain reaction (PCR). Background: Bacterial…
  • 2016 International Congress

    Real-world safety of deep brain stimulation in patients with ≤7.5 years between disease onset and device implant

    M.C. Schiess, L. Tonder, M. Wells, T. Weaver, V. Stoker (Houston, TX, USA)

    Objective: The intent of this analysis was to characterize real-world safety of deep brain stimulation (DBS) in patients with ≤7.5 years between Parkinson's disease (PD)…
  • 2016 International Congress

    The effect of STN-DBS on movement initiation control is modulated by the noradrenergic system: Evidence of an interaction from a combined pharmacological/DBS/EEG study

    C. Spay, M. Albares, S. Thobois, E. Broussolle, P. Boulinguez, B. Ballanger (Bron, France)

    Objective: Assessing the role of the noradrenergic system underlying the effect of subthalamic nucleus stimulation (STN-DBS) on akinesia. Background: Slowness in movement initiation, associated with…
  • 2016 International Congress

    Chronic directional subthalamic nucleus deep brain stimulation in Parkinson’s disease – A pilot study

    P. Reker, T.A. Dembek, A. Gierich, J. Wirths, H.S. Dafsari, J. Roediger, M.T. Barbe, L. Timmermann, V. Visser-Vandewalle (Cologne, Germany)

    Objective: This pilot study aimed to assess the therapeutic potential of chronically implanted directional DBS leads in patients with Parkinson's disease. Background: The therapeutic effect…
  • 2016 International Congress

    Long-term responsive deep brain stimulation in Tourette syndrome

    R.A. Molina, J.B. Shute, P.J. Rossi, E. Opri, K.D. Foote, M.S. Okun, A. Gunduz (Gainesville, FL, USA)

    Objective: To develop and measure the effectiveness of responsive deep brain stimulation for the treatment of Tourette syndrome. Background: Tourette's Syndrome (TS) is a paroxysmal…
  • 2016 International Congress

    A multi-site survey of Parkinson’s disease deep brain stimulation center best practice: moving toward a standard of care for DBS

    A.A. Butala, K.A. Mills, P. Schmidt, M.S. Okun, Z. Mari (Baltimore, MD, USA)

    Objective: To survey how Deep Brain Stimulation (DBS) Centers handle referrals and peri-operative (surgical and non-surgical) treatment of persons with Parkinson's disease (PD). Background: Currently…
  • 2016 International Congress

    Evaluating the effects of deep brain stimulation (DBS) in mice with spinocerebellar ataxia (SCA1)

    V. Vedam-Mai, K. McFarland, Q. Zhang, H. Kim, R. Nathu, S. Kurtovic, K. Savery, T. Ashizawa, M.S. Okun (Gainesville, FL, USA)

    Objective: To determine the therapeutic effects of Deep Brain Stimulation (DBS) in mice with Spinocerebellar Ataxia (SCA1). Background: Ataxia is a movement disorder affecting balance…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • #24752 (not found)
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley